BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hirayama S, Iwai T, Higashi E, Nakamura M, Iwamatsu C, Itoh K, Nemoto T, Tanabe M, Fujii H. Discovery of δ Opioid Receptor Full Inverse Agonists and Their Effects on Restraint Stress-Induced Cognitive Impairment in Mice. ACS Chem Neurosci 2019;10:2237-42. [PMID: 30913383 DOI: 10.1021/acschemneuro.9b00067] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Shi J, Li L, Li Y. o -Silylaryl Triflates: A Journey of Kobayashi Aryne Precursors. Chem Rev 2021;121:3892-4044. [DOI: 10.1021/acs.chemrev.0c01011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 26.0] [Reference Citation Analysis]
2 Zheng Z, van der Werf A, Deliaval M, Selander N. Synthesis of Fluorinated Amide Derivatives via a Radical N-Perfluoroalkylation-Defluorination Pathway. Org Lett 2020;22:2791-6. [PMID: 32208612 DOI: 10.1021/acs.orglett.0c00768] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Fujii H, Uchida Y, Shibasaki M, Nishida M, Yoshioka T, Kobayashi R, Honjo A, Itoh K, Yamada D, Hirayama S, Saitoh A. Discovery of δ opioid receptor full agonists lacking a basic nitrogen atom and their antidepressant-like effects. Bioorg Med Chem Lett 2020;30:127176. [PMID: 32299730 DOI: 10.1016/j.bmcl.2020.127176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hirayama S, Fujii H. δ Opioid Receptor Inverse Agonists and their In Vivo Pharmacological Effects. Curr Top Med Chem 2020;20:2889-902. [PMID: 32238139 DOI: 10.2174/1568026620666200402115654] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Iwai T, Kikuchi A, Oyama M, Watanabe S, Tanabe M. Mirogabalin prevents repeated restraint stress-induced dysfunction in mice. Behav Brain Res 2020;383:112506. [PMID: 31982462 DOI: 10.1016/j.bbr.2020.112506] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
6 Iwamatsu C, Hayakawa D, Kono T, Honjo A, Ishizaki S, Hirayama S, Gouda H, Fujii H. Effects of N-Substituents on the Functional Activities of Naltrindole Derivatives for the δ Opioid Receptor: Synthesis and Evaluation of Sulfonamide Derivatives. Molecules 2020;25:E3792. [PMID: 32825410 DOI: 10.3390/molecules25173792] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tanguturi P, Pathak V, Zhang S, Moukha-Chafiq O, Augelli-Szafran CE, Streicher JM. Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) Antagonists. Molecules 2021;26:6693. [PMID: 34771099 DOI: 10.3390/molecules26216693] [Reference Citation Analysis]
8 Higashi E, Hirayama S, Nikaido J, Shibasaki M, Kono T, Honjo A, Ikeda H, Kamei J, Fujii H. Development of Novel δ Opioid Receptor Inverse Agonists without a Basic Nitrogen Atom and Their Antitussive Effects in Mice. ACS Chem Neurosci 2019;10:3939-45. [PMID: 31397148 DOI: 10.1021/acschemneuro.9b00368] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]